Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DT5I
|
|||
| Drug Name |
PMID28766366-Compound-Scheme9EHT3356
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
DIAXONHIT LEBLOND, Bertrand CASAGRANDE, Anne-Sophie DESIRE, Laurent FOUCOURT, Alicia BESSON, Thierry
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H15N5OS
|
|||
| Canonical SMILES |
CC1=CC=C(C=C1)NC2=NC=NC3=C2C4=C(C=C3)N=C(S4)C(=N)OC
|
|||
| InChI |
1S/C18H15N5OS/c1-10-3-5-11(6-4-10)22-17-14-12(20-9-21-17)7-8-13-15(14)25-18(23-13)16(19)24-2/h3-9,19H,1-2H3,(H,20,21,22)
|
|||
| InChIKey |
AVKKQBJQERVCTD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target Info | Inhibitor | [1] |
| Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target's Patent Info | [1] | |
| Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B) | Target's Patent Info | [1] | ||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.